Literature DB >> 34785028

Symptom experience of limited cutaneous systemic sclerosis from the Patients' perspective: A qualitative study✰,✰✰,★,★★.

Alain Lescoat1, Susan L Murphy2, Yen T Chen3, Nadia Vann4, Francesco Del Galdo5, David Cella6, Maya H Buch7, Dinesh Khanna8.   

Abstract

OBJECTIVES: Limited cutaneous systemic sclerosis (lcSSc) is the largest subgroup of people with SSc, but little is known about symptom experience from the patients' perspective. This study aimed to comprehensively identify domains and symptoms reported as bothersome by patients with lcSSc and to analyze themes and sub-themes capturing symptom experience in this population.
METHODS: Focus groups of patients with lcSSc were conducted using a structured guide. Patients were recruited based on an a priori purposive framework to include men and women with SSc. Focus groups were recorded, transcribed, anonymized, and analyzed using the RADaR technique (rigorous and accelerated data reduction) combined with iterative, deductive and inductive approaches.
RESULTS: Four 2-hour Focus groups comprising participants with lcSSc were conducted (N = 26). Ninety-four symptoms were identified with 22 domains. Symptoms from the following domains were mentioned in all Focus groups: skin, musculoskeletal (MSK), cardiac, pulmonary, gastro-intestinal (GI) manifestations, fatigue, sleep, Raynaud's phenomenon (RP), pain, and digital ulcers. The three most cited domains in a pre-meeting survey were GI, RP and MSK. Seven themes defining symptom experience were identified: difficulty attributing symptoms to this complex systemic disease, influence of symptom temporality, impairment of emotional well-being, limitations in functioning (including several sub-themes of functioning), survival, symptoms management and uncertainty.
CONCLUSION: This study comprehensively identified domains and symptoms considered bothersome from the perspective of patients with lcSSc and summarized patient experience of lcSSc-related symptoms. This study is the first step in the design of a future combined response index dedicated to lcSSc that could foster specific research on this subpopulation of patients.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Combined response index; Domains; Limited cutaneous systemic sclerosis; Qualitative analysis; Scleroderma; Symptoms experience

Mesh:

Year:  2021        PMID: 34785028      PMCID: PMC9131352          DOI: 10.1016/j.semarthrit.2021.11.003

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.431


  37 in total

Review 1.  Criteria for the classification of early systemic sclerosis.

Authors:  E C LeRoy; T A Medsger
Journal:  J Rheumatol       Date:  2001-07       Impact factor: 4.666

2.  'Best practice' in focus group research: making sense of different views.

Authors:  Tim Freeman
Journal:  J Adv Nurs       Date:  2006-12       Impact factor: 3.187

3.  The scope and consistency of outcomes reported in trials in patients with systemic sclerosis.

Authors:  Daniel Sumpton; Adrien Bigot; Benedicte Sautenet; Jonathan C Craig; Geraldine Hassett; Vivek Thakkar; Peter Tugwell; Allison Tong
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-07-15       Impact factor: 4.794

4.  Multicenter Qualitative Study Exploring the Patient Experience of Digital Ulcers in Systemic Sclerosis.

Authors:  Michael Hughes; John D Pauling; Jennifer Jones; Christopher P Denton; Robyn T Domsic; Tracy M Frech; Ariane L Herrick; Dinesh Khanna; Marco Matucci-Cerinic; Lorraine McKenzie; Lesley Ann Saketkoo; Rachael Gooberman-Hill; Andrew Moore
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-05       Impact factor: 4.794

5.  Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes.

Authors:  I B Wilson; P D Cleary
Journal:  JAMA       Date:  1995-01-04       Impact factor: 56.272

6.  Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database.

Authors:  Camelia Frantz; Dorte Huscher; Jérôme Avouac; Eric Hachulla; Alexandra Balbir-Gurman; Gabriela Riemekasten; Elise Siegert; Maria-Grazia Lazzaroni; Patricia E Carreira; Serena Vettori; Elisabetta Zanatta; Susanne Ullman; Laszlo Czirjàk; Otylia Kowal-Bielecka; Oliver Distler; Marco Matucci-Cerinic; Yannick Allanore
Journal:  Autoimmun Rev       Date:  2019-12-12       Impact factor: 9.754

7.  Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis.

Authors:  Anna-Maria Hoffmann-Vold; Øyvind Molberg; Øyvind Midtvedt; Torhild Garen; Jan Tore Gran
Journal:  J Rheumatol       Date:  2013-05-01       Impact factor: 4.666

8.  Concepts of functioning and health important to people with systemic sclerosis: a qualitative study in four European countries.

Authors:  Tanja A Stamm; Malin Mattsson; Carina Mihai; Juliane Stöcker; Alexa Binder; Bettina Bauernfeind; Georg Stummvoll; Gunvor Gard; Roger Hesselstrand; Gunnel Sandqvist; Oana Draghicescu; Ana Maria Gherghe; Malina Voicu; Klaus P Machold; Oliver Distler; Josef S Smolen; Carina Boström
Journal:  Ann Rheum Dis       Date:  2011-06       Impact factor: 19.103

9.  Methodological Aspects of Focus Groups in Health Research: Results of Qualitative Interviews With Focus Group Moderators.

Authors:  Anja P Tausch; Natalja Menold
Journal:  Glob Qual Nurs Res       Date:  2016-03-14

10.  Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort.

Authors:  Sara Jaafar; Alain Lescoat; Suiyuan Huang; Jessica Gordon; Monique Hinchcliff; Ami A Shah; Shervin Assassi; Robyn Domsic; Elana J Bernstein; Virginia Steen; Sabrina Elliott; Faye Hant; Flavia V Castelino; Victoria K Shanmugam; Chase Correia; John Varga; Vivek Nagaraja; David Roofeh; Tracy Frech; Dinesh Khanna
Journal:  Arthritis Res Ther       Date:  2021-06-14       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.